drugset

drugset / Trial / NCT07853040

A Study to Evaluate the Pharmacokinetics and Safety of INCB161734 in Participants With Hepatic Impairment

NCT07853040 ↗

Phase 1 Not yet recruiting 24 enrolled Incyte Corporation

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study is conducted to evaluate the pharmacokinetics and safety of INCB161734 in participants with hepatic impairment.

Timeline

Start: 2026-10-13
Primary completion: 2027-03-31
Completion: 2027-03-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	INCB161734	Unknown	—	Oral

Indications